COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?

被引：1
|
作者：
Sen, Selcuk [1 ]
Uresin, Ali Yagiz [1 ]
机构：
[1] Istanbul Univ, Istanbul Fac Med, Div Clin Pharmacol, Dept Med Pharmacol, Istanbul, Turkey
来源：
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY | 2020年 / 48卷 / 07期
关键词：
ACE2;
D O I：
10.5543/tkda.2020.64072
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：631 / 634
页数：4
相关论文
共 50 条
  • [1] COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial
    Mancia, Giuseppe
    [J]. CARDIOVASCULAR RESEARCH, 2020, 116 (14) : E198 - E199
  • [2] RAAS Inhibitors and Risk of Covid-19
    Islam, Nazrul
    Khunti, Kamlesh
    Chowell, Gerardo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20): : 1992 - 1992
  • [3] Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
    Esteban-Lucia, L.
    Chacon, M. A. Zambrano
    Rodriguez, A. M. Venegas
    Devesa-Arbiol, A.
    Gonzalez-Rodriguez, M.
    Maure-Blesa, L.
    Avila-Barahona, P.
    Pello-Lazaro, A. M.
    Gonzalez-Lorenzo, O.
    Kallmeyer-Mayor, A. M.
    Fernandez-Roblas, R.
    Villar-Alvarez, F.
    Tunon, J.
    Navarro, A. Acena
    Franco-Pelaez, J. A.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 3006 - 3006
  • [4] RAAS inhibitors in COVID-19: They are not all the same!
    Kow, Chia Siang
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2023, 42 (09) : 815 - 816
  • [5] RAAS Inhibitors and Risk of Covid-19 REPLY
    Reynolds, Harmony R.
    Adhikari, Samrachana
    Iturrate, Eduardo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20): : 1993 - 1994
  • [6] RAAS Inhibition and Risk of AKI in COVID-19
    Birkelo, Bethany
    Perkins, Amy
    Greevy, Robert
    Parr, Sharidan
    Hung, Adriana
    Ornelas, Juan Pablo Arroyo
    Matheny, Michael E.
    Siew, Edward D.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 67 - 67
  • [7] Role of the RAAS in mediating the pathophysiology of COVID-19
    Jasiczek, Jakub
    Doroszko, Adrian
    Trocha, Tymoteusz
    Trocha, Malgorzata
    [J]. PHARMACOLOGICAL REPORTS, 2024, 76 (03) : 475 - 486
  • [8] RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
    Holmes, Adam R.
    Nelson, Jacob
    Hirschl, Jacob
    Perkins, Sidney J.
    Chopra, Zoey
    Fung, Christopher
    Medlin, Richard P., Jr.
    Korley, Frederick K.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3073 - 3073
  • [9] COVID-19 and RAAS inhibitors: is there a final conclusion?
    Talebi-Taher, Mahshid
    Najafi, Mohammad Hosein
    Behzad, Shima
    [J]. IRANIAN JOURNAL OF MICROBIOLOGY, 2021, 13 (06) : 728 - 736
  • [10] RAAS inhibitors do not increase the risk of COVID-19
    Fernandez-Ruiz, Irene
    [J]. NATURE REVIEWS CARDIOLOGY, 2020, 17 (07) : 383 - 383
12345